Posts Tagged: Galderma Labs v. Tolmar
Federal Circuit Treatment of ‘Commercial Success’ in Hatch-Waxman Cases
In order to establish that the commercial success factor supports a non-obviousness finding, the patentee must establish that a connection (or nexus) exists between the novel aspects …
Federal Circuit Treatment of Inherency Arguments Aimed at Method of Treatment Patent Claims
This article examines Federal Circuit case law analyzing validity challenges to method of treatment patent claims where the claims at issue are alleged to recite an inherent …
Analyzing obviousness and anticipation challenges to claims directed to an isolated component of a prior art mixture
Based on the governing Federal Circuit case law, where the patent claim at issue is directed to a specific component (such as a specific enantiomer) of a …
